Review of the Correlation of LAT1 With Diseases: Mechanism and Treatment
Обзор взаимосвязи LAT1 с заболеваниями: механизмы и методы лечения
2020-10-20
SCID: 54.1/tc523cuv
Discuss with AI
LAT1 transporterLAT1-related diseasesamino acid transportcancer treatmentsystem L transporter
Figures from the paper
Abstract (AI)
LAT1 is a member of the system L transporter family. The main role of the LAT1 is to transport specific amino acids through cell membranes to provide nutrients to cells and participate in several metabolic pathways. It also contributes to the transport of hormones and some drugs, which are essential for the development and treatment of some diseases. In recent years, many studies have shown that LAT1 is related to cancer, obesity, diabetes, and other diseases. However, the specific mechanism underlying the influence of LAT1 on such conditions remains unclear. Through the increasing number of studies on LAT1, we have obtained a preliminary understanding on the function of LAT1 in diseases. These studies also provide a theoretical basis for finding treatments for LAT1-related diseases, such as cancer. This review summarizes the function and mechanism of LAT1 in different diseases and the treatment of LAT1-related diseases. It also provides support for the development of novel and reliable disease treatments.
Key Findings
1
Accumulating studies associate LAT1 with cancer, obesity, diabetes, and other diseases, although the underlying mechanisms remain incompletely understood.
2
Existing research provides a preliminary understanding of LAT1 functions in disease and a theoretical basis for developing treatments, particularly for cancer.
3
LAT1 also transports hormones and certain drugs, linking its activity to disease development and therapeutic responses.
4
LAT1 is a system L transporter that moves specific amino acids across cell membranes, supporting cellular nutrition and metabolic pathways.
5
The review summarizes LAT1 mechanisms across diseases and evaluates treatment strategies for LAT1-related conditions, supporting development of new therapies.
Research Object
LAT1 (system L transporter 1) in diseases, including cancer, obesity, and diabetes
Research Subject
LAT1 functions and mechanisms in disease pathogenesis, and therapeutic approaches targeting LAT1-related diseases
Publication Details
Publication Date
2020-10-20
Journal
Publisher
ISSN
Cited by
90
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai5
Global cancer statistics2011
The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health2018
The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer2019
L-Type amino acid transporter 1 as a target for drug delivery2020
Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)2017
Cited by4
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications2025
L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review)2025
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-2112024
LAT1 supports mitotic progression through Golgi unlinking in an amino acid transport activity-independent manner2024